Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.
Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.
Senate approves NIH funding bill. NCI awards $25 million to eight institutions for patient navigator programs; $35 million awarded for nanotechnology partnerships.
NIH-funded HapMap consortium publishes first phase of catalog.
NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding.
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Ted Kennedy, RFK Jr.’s uncle, shaped the National Cancer Program. Will his nephew follow suit?
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State